Skip to content

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

Press Releases

Choose Year
Search Press Releases

Found 94 Results

June 25, 2021

Surrozen Presents Data at 2021 International Liver Conference for Wnt-Modulating Antibody SZN-043

June 17, 2021

Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Biology Conference: Fundamental Mechanisms and Translational Applications

June 1, 2021

Surrozen Publishes Article in Nature Communications Demonstrating Selective Wnt Mimetics Stimulate Bone Mass Accrual in Disease Models of Osteoporosis,Aging and Long-Bone Fracture

May 24, 2021

Surrozen Presents Data from Lead Wnt-Modulating Antibody Programs, SZN-1326 and SZN-043,in Six Oral and Poster Presentations at 2021 Digestive Disease Week Conference

May 6, 2021

Surrozen Strengthens Board of Directors with Appointments of Mace Rothenberg, M.D.,and Christopher Chai

April 15, 2021

Surrozen and Consonance-HFW Acquisition Corp. Announce Business Combination, Creating Publicly Listed Leader in Wnt Biology and Tissue Regeneration

March 11, 2021

Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho,Ph.D.

February 2, 2021

Surrozen Expands Board of Directors with Appointment of Shao-Lee Lin, M.D.,Ph.D.

November 12, 2020

Surrozen to Present at the Stifel 2020 Virtual Healthcare Conference

October 29, 2020

Surrozen Appoints Charles Williams as Chief Financial Officer

«...6 789 10 »

IR Contact

Email: investorinfo@surrozen.com

Email Alerts Sign-Up

Email

Unsubscribe

Loading...

Company

About
Management
Board of Directors
Scientific Advisors
Contact
Careers

Science

Science
Pipeline
Publications

Investors

Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs

Copyright © 2026 Surrozen. All Rights Reserved

Privacy Policy
FCOI Policy
Accessibility

Scroll to Top